Investor Relations

Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research. The Company has developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Combining recent advances in nanofabrication, biochemistry, molecular biology, surface chemistry and optics, Pacific Biosciences has created a powerful technology platform called single molecule, real-time, or SMRT™, technology. SMRT technology enables real-time analysis of biomolecules with single molecule resolution, which has the potential to transform the understanding of biological systems by providing a window into these systems that has not previously been open for scientific study.

Featured Event

Aug 5, 2015 at 4:30 PM ET
Pacific Biosciences of California, Inc. Second Quarter 2015 Earnings Conference Call

Recent News

August 5, 2015
Pacific Biosciences of California, Inc. Announces Second Quarter 2015 Financial Results

MENLO PARK, Calif., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ:PACB) today reported a 118% increase in revenue with $24.9 million for the second quarter ended Jun...

July 20, 2015
Macrogen Named PacBio Certified Service Provider

MENLO PARK, Calif. - July 20, 2015 - Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II Sequencing System, today announced that Macrogen Inc of Korea ha...

Events & Presentations

Sep 16, 2015
2015 Morgan Stanley Global Healthcare Conference
Dec 2, 2015
Evercore ISI MedTools & Oursourcing Investor Forum

Stock Quote

Last Trade
4:00 PM ET
Aug 28, 2015
Change (%)
52 Week High
52 Week Low
Day High
Day Low


Pacific Biosciences

1380 Willow Rd.
Menlo Park, CA 94025
(650) 521-8450

Supernav grey background

Supernav grey background

Super Navigation block